Cancer Registry Software Market
Cancer Registry Software Market Size, Share & Trends Analysis Report, By Deployment Model (On-Premise, Cloud-based), By Database Type (Commercial Database, Public Database), By End-User Industry (Government & Third Party, Private Payers, Hospital & Medical Practice, Others) Forecast Period (2022-2030)
Cancer registry software market is anticipated to grow at a significant CAGR of 10.5% during the forecast period. The increasing prevalence of cancer, improving quality of care, and reducing healthcare costs along with recent developments by key players are driving the growth of the global cancer registry software market. According to the World Health Organization, Cancer was a leading cause of mortality worldwide, accounting for nearly 10 million mortalities in 2020, or nearly one in six casualties. The most common cancers include breast, lung, colon rectum, and prostate cancers. Additionally, according to estimates from the International Agency for Research on Cancer (IARC) updates from July 2021, by 2040, the global burden of cancers is expected to grow to 27.5 million new cancer cases and 16.3 million casualties globally. Such high burdens will increase the demand for cancer registry software as it would provide significant benefits in identifying the trend related to the prevalence and treatment of cancer.
Estimated numbers of survivors for the 5 most prevalent cancers among Men in the US as of January 1, 2022 (in’ 000)
Source: American Cancer Society, Inc.
With high cancer prevalence and rapid adoption of cancer registry software, the market is likely to grow. However, privacy and security concerns for patient data will be a restraint in the market growth. However, the growing involvement of the government in the promotion of this software is likely to offer lucrative opportunities for the growth of the global cancer registry software market.
Segmental Outlook
The global cancer registry software market is segmented based on deployment model, database type, and end-user industry. Based on the deployment model, the market is segmented into cloud-based and on-premises. Based on database type, the market is segmented into commercial databases and public databases. Based on the end-user industry, the market is segmented into government & third party, private payers, hospital & medical practice, and others.
Hospital and Medical Practice Held a Considerable Share in the Global Cancer Registry Software Market
Hospital & medical practice held a considerable share of the global cancer registry software market in 2022. The rising number of cancer-related procedures in hospitals is contributing to the high share of the regional market. Patients have been relying on hospitals as primary care centers, which is likely to drive the growth of this market segment. Sri Lanka is one of the Member States of the World Health Organisation’s South-East Asia Region and receives technical support for cancer registration from the International Agency for Research on Cancer (IARC), and the IARC Regional Hub based at the Tata Memorial Centre in Mumbai, India.
For data management of cancer registry records, the Sri Lanka National Cancer Registry (SLNCR) uses the open-source registry software tool, CanReg5, as developed by IARC. The SLNCR has received data from 25 centers located across the country. District General Hospital, Avissawella, Provincial General Hospital, Badulla, District General Hospital, Chilaw, Teaching Hospital, Kalutaram, District General Hospital, General Hospital, Vavuniya, and Apeksha Hospital (National Cancer Institute) are the major Sri Lankan Hospitals that are currently using cancer registry software.
Regional Outlooks
The global cancer registry software market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America).
Global Cancer Registry Software Market Growth, by Region 2023-2030
Asia-Pacific to exhibit Highest Growth in the Global Cancer registry software Market
Regional growth is attributed to an increasing adoption of technology in the healthcare sector. Also increasing cases of cancer in the region is promoting the adoption of cancer registry software to identify the pattern of cancer for its better treatment. According to the Indian Council of Medical Research-National Cancer Registry Programme (ICMR-NCRP), the government informed Parliament the number of cancer cases in the country is projected to go up from $17.7 million in 2022 to $19.0 million in 2025. For instance, NITI Aayog, the public policy think tank of the Indian Government, aims to build an Imaging Biobank in association with the Department of Biotechnology, wherein it will create a database of cancer-related pathology and radiology images of more than 20,000 profiles of patients. Such images are creating a huge database for cancer registries; thereby driving the regional market growth.
Market Players Outlook
The major companies serving the global cancer registry software market include IBM Corp., Elekta, McKesson Corp., Siemens Healthineers, and Epic Systems among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2022, Electronic Registry Systems (ERS) Inc. and Nursenav Inc., an oncology navigation software, partnered to integrate their flagship software solutions, CRStar and CONNECT. This integration leverages cancer registry workflows and data collection to support services provided by oncology navigation. The integration between CRStar and CONNECT supports the creation of survivorship care plans by transmitting the diagnosis and treatment data directly into the patient's plan in CONNECT.
The Report Covers
- Market value data analysis of 2022 and forecast to 2030.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global cancer registry software market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. IBM Corp.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Siemens Healthineers
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. McKesson Corp.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Other
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
4. Market Segmentation
4.1. Global Cancer Registry Software Market by Database Type
4.1.1. Commercial Database
4.1.2. Public Database
4.2. Global Cancer Registry Software Market by Deployment Model
4.2.1. Cloud Based
4.2.2. On-Premises
4.3. Global Cancer Registry Software Market by End-User Industry
4.3.1. Government & Third Party
4.3.2. Private Players
4.3.3. Hospital & Medical Practice
4.3.4. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
5.4.1. Latin America
5.4.2. Middle East and Africa
6. Company Profiles
6.1. C/NET Solutions
6.2. Conduent, Inc.
6.3. Electa
6.4. Electronic Registry System, Inc.
6.5. Epic Systems
6.6. ERS, Inc.
6.7. himagine solutions
6.8. Inspirata, Inc.
6.9. NeuralFrame, Inc.
6.10. Onco, Inc.
6.11. Ordinal Data Inc
6.12. Redsson, Ltd.,
6.13. Rocky Mountain Cancer Data Systems
1. GLOBAL CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DATABASE TYPE, 2022-2030 ($ MILLION)
2. GLOBAL CANCER REGISTRY COMMERCIAL DATABASE SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
3. GLOBAL CANCER REGISTRY PUBLIC DATABASE SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
4. GLOBAL CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODEL, 2022-2030 ($ MILLION)
5. GLOBAL CLOUD BASED CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
6. GLOBAL ON-PREMISES CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
7. GLOBAL CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER INDUSTRY, 2022-2030 ($ MILLION)
8. GLOBAL CANCER REGISTRY SOFTWARE FOR GOVERNMENT & THIRD PARTY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
9. GLOBAL CANCER REGISTRY SOFTWARE FOR HEALTHCARE & LIFESCIENCES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
10. GLOBAL CANCER REGISTRY SOFTWARE FOR HOSPITAL & MEDICAL PRACTICE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
11. GLOBAL CANCER REGISTRY SOFTWARE FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
12. GLOBAL CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
13. NORTH AMERICAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
14. NORTH AMERICAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DATABASE TYPE, 2022-2030 ($ MILLION)
15. NORTH AMERICAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODEL, 2022-2030 ($ MILLION)
16. NORTH AMERICAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER INDUSTRY, 2022-2030 ($ MILLION)
17. EUROPEAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
18. EUROPEAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DATABASE TYPE, 2022-2030 ($ MILLION)
19. EUROPEAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODEL, 2022-2030 ($ MILLION)
20. EUROPEAN CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER INDUSTRY, 2022-2030 ($ MILLION)
21. ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
22. ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DATABASE TYPE, 2022-2030 ($ MILLION)
23. ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODEL, 2022-2030 ($ MILLION)
24. ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER INDUSTRY, 2022-2030 ($ MILLION)
25. REST OF THE WORLD CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
26. REST OF THE WORLD CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DATABASE TYPE, 2022-2030 ($ MILLION)
27. REST OF THE WORLD CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODEL, 2022-2030 ($ MILLION)
28. REST OF THE WORLD CANCER REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER INDUSTRY, 2022-2030 ($ MILLION)
1. GLOBAL CANCER REGISTRY SOFTWARE MARKET SHARE BY DATABASE TYPE, 2022 VS 2030(%)
2. GLOBAL CANCER REGISTRY SOFTWARE MARKET SHARE BY DEPLOYMENT MODEL, 2022 VS 2030(%)
3. GLOBAL CANCER REGISTRY SOFTWARE MARKET SHARE BY END-USER INDUSTRY, 2022 VS 2030(%)
4. GLOBAL CANCER REGISTRY COMMERCIAL DATABASE MARKET SHARE BY REGION, 2022 VS 2030(%)
5. GLOBAL CANCER REGISTRY PUBLIC DATABASE MARKET SHARE BY REGION, 2022 VS 2030(%)
6. GLOBAL CLOUD BASED CANCER REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030(%)
7. GLOBAL ON-PREMISES CANCER REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030(%)
8. GLOBAL CANCER REGISTRY SOFTWARE FOR GOVERNMENT & THIRD PARTY MARKET SHARE BY REGION, 2022 VS 2030(%)
9. GLOBAL CANCER REGISTRY SOFTWARE FOR HEALTHCARE & LIFESCIENCES MARKET SHARE BY REGION, 2022 VS 2030(%)
10. GLOBAL CANCER REGISTRY SOFTWARE FOR HOSPITAL & MEDICAL PRACTICE MARKET SHARE BY REGION, 2022 VS 2030(%)
11. GLOBAL CANCER REGISTRY SOFTWARE FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030(%)
12. GLOBAL CANCER REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030(%)
13. US CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
14. CANADA CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
15. UK CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
16. FRANCE CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
17. GERMANY CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
18. ITALY CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
19. SPAIN CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
20. REST OF EUROPE CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
21. INDIA CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
22. CHINA CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
23. JAPAN CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
24. SOUTH KOREA CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
25. REST OF ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
26. LATIN AMERICA CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
27. MIDDLE EAST AND AFRICA CANCER REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
